Literature DB >> 30443842

The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL).

Mehdi Allahbakhshian Farsani1,2, Masomeh Kamel1,2, Mahdieh Mehrpouri1,2, Reza Shiri Heris1,2, Mohsen Hamidpour3,4, Sina Salari5, Mohamad Hosien Mohamadi1,2.   

Abstract

Interferon gamma (IFN-γ) and interleukin 6 (IL-6) are including the most important cytokines which have been associated with the biological behavioral and immune responses in malignancies. Based on the critical roles which these two cytokines play against tumor cells, the present study was aimed to investigate the genes expression level of IL6 and IFN-γ in patients with Acute Lymphoblastic Leukemia and compare with normal controls. Fifty-two patients with ALL and 13 healthy volunteer were under studied. The peripheral blood mononuclear cells of all patients and normal controls were separated by ficoll. The expression of interferon gamma and interleukin 6 genes were determined by RQ-PCR. Finally all data were analyzes using T student, one way ANOVA and Mann-Whitney tests were use to analyze all samples data. Our finding showed that the level of IFN-γ gene expression was significant decreased in patients with All as compared with healthy controls (83 change fold, p < 0.0001). The level of IL-6 Gene expression was not changeable in B-ALL patients as compared with healthy control (p = 0.4), but in T-ALL patients, was significantly reduced (p < 0.01). The results of present study indicated that IFN-γ gene expression reduced in ALL patients. It provides a valuable insight that immune system may disrupted in patients with ALL, which cause tumor cells escape from immune surveillance.

Entities:  

Keywords:  ALL; IFN-γ; IL-6

Year:  2018        PMID: 30443842     DOI: 10.1007/s12253-018-0536-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

Review 1.  The expression of IL-6 and its related genes in acute leukemia.

Authors:  H Sugiyama; K Inoue; H Ogawa; T Yamagami; T Soma; S Miyake; M Hirata; T Kishimoto
Journal:  Leuk Lymphoma       Date:  1996-03

Review 2.  Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications.

Authors:  B A Cardoso; A Gírio; C Henriques; L R Martins; C Santos; A Silva; J T Barata
Journal:  Braz J Med Biol Res       Date:  2008-04-30       Impact factor: 2.590

3.  Proinflammatory cytokines during the initial phase of oral mucositis in patients with acute lymphoblastic leukaemia.

Authors:  Thais Morales-Rojas; Ninoska Viera; Alejandra Morón-Medina; Carmen Julia Alvarez; Alejandra Alvarez
Journal:  Int J Paediatr Dent       Date:  2011-09-15       Impact factor: 3.455

4.  Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence.

Authors:  Shuling Wu; Reinhard Gessner; Arend von Stackelberg; Renate Kirchner; Guenter Henze; Karl Seeger
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells.

Authors:  Michael T Brady; Jaewoo Lee; Soldano Ferrone; Eunice S Wang; Meir Wetzler
Journal:  Leuk Res       Date:  2010-10-12       Impact factor: 3.156

6.  The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF.

Authors:  A Pituch-Noworolska; J Wieckiewicz; M Gawlicka; M Wołoszyn; I Ruggiero; M Zembala
Journal:  Haematologia (Budap)       Date:  1998

Review 7.  Systematic review of the association between circulating interleukin-6 (IL-6) and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  Eur J Cancer       Date:  2008-04-01       Impact factor: 9.162

8.  Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels.

Authors:  Beatriz Sanchez-Correa; Juan M Bergua; Carmen Campos; Inmaculada Gayoso; Maria Jose Arcos; Helena Bañas; Sara Morgado; Javier G Casado; Rafael Solana; Raquel Tarazona
Journal:  Cytokine       Date:  2013-01-26       Impact factor: 3.861

9.  Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.

Authors:  B Bauvois; J Nguyen; R Tang; C Billard; J-P Kolb
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

10.  Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

Authors:  Christian Marth; Heidi Fiegl; Alain G Zeimet; Elisabeth Müller-Holzner; Martina Deibl; Wolfgang Doppler; Günter Daxenbichler
Journal:  Am J Obstet Gynecol       Date:  2004-11       Impact factor: 8.661

View more
  6 in total

1.  The Expression of P53, MDM2, c-myc, and P14ARF Genes in Newly Diagnosed Acute Lymphoblastic Leukemia Patients.

Authors:  Mehdi Allahbakhshian Farsani; Mohammad Rafiee; Hamideh Aghaee Nezhad; Sina Salari; Arshia Gharehbaghian; Mohammad Hossein Mohammadi
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-16       Impact factor: 0.900

2.  Evaluation of Sestrin 2, Adiponectin, AMPK, and mTOR Genes Expression in Acute Myeloid Leukemia Patients.

Authors:  Seyed Hossein Abtahi; Mohammad Hossein Mohammadi; Mehdi Allahbakhshian Farsani; Zahra Aghelan; Sina Salari
Journal:  Iran J Biotechnol       Date:  2021-04-01       Impact factor: 1.671

Review 3.  Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.

Authors:  Silvia Jiménez-Morales; Ivan Sammir Aranda-Uribe; Carlos Jhovani Pérez-Amado; Julian Ramírez-Bello; Alfredo Hidalgo-Miranda
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

4.  Investigating the expression pattern of the angiopoietin-Tie system in ALL and its correlation with baseline characteristics.

Authors:  Saeed Zaka Khosravi; Samira Molaei Ramshe; Mehdi Allahbakhshian Farsani; Saeed Solali; Mohammadreza Moonesi; Majid Farshdousti Hagh
Journal:  Blood Res       Date:  2021-06-30

Review 5.  Genetics of blood malignancies among Iranian population: an overview.

Authors:  Majid Ghayour-Mobarhan; Amir Sadra Zangouei; Seyed Mohammad Hosseinirad; Majid Mojarrad; Meysam Moghbeli
Journal:  Diagn Pathol       Date:  2020-05-06       Impact factor: 2.644

6.  A Novel Aurora Kinase Inhibitor Attenuates Leukemic Cell Proliferation Induced by Mesenchymal Stem Cells.

Authors:  Jun-Dan Wang; Wei Zhang; Jing-Wen Zhang; Ling Zhang; Le-Xun Wang; Hong-Sheng Zhou; Liang Long; Gui Lu; Quentin Liu; Zi-Jie Long
Journal:  Mol Ther Oncolytics       Date:  2020-08-05       Impact factor: 7.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.